To explore Kaiser Permanente Northern California studies search keywords, find by program, find by specialty or find by study status.
Cardiology
Kaiser Permanente Stratification & Health Outcomes of Cardiogenic shocK (KP-SHOCK)
Sirtaz Adatya, Ankeet Bhatt | Delivery Science Grants Program | 2026
Kaiser Permanente Artificial Intelligence Echocardiogram Interpretation for Systematic Integration and Guided Healthcare Transformation (The KP AI ECHO INSIGHT Study)
Keane Lee, David Ouyang | Delivery Science Grants Program | 2026
Development of a Predictive Risk Model for 1-Year Major Adverse Cardiovascular Events (MACE) and Days Alive and Out of Hospital (DAOH) in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Ahmed Shah | Community Health | 2026
Adults with Congenital Heart Disease in a Large Integrated Health System: Understanding Predictors of Guideline-Based Referral to and Follow Up with Specialty Care.
Alison Meadows | Community Health | 2026
The Incidence of Amiodarone Toxicity in a Large Contemporary Community-Based Cohort
Robert Hayward | Community Health | 2026
Epidemiology and Clinical History and Outcomes in Mixed Aortic Valve Disease (ECHO-MAVD) Study
Jesse Fitzpatrick | Community Health | 2026
Diuretic Initiation and Utilization: Rigorous Evaluation of Strategy Effectiveness in Heart Failure (DIURESE-HF)
Ankeet Bhatt | Community Health | 2026
Prevalence and relationship of Pre-Diabetes with risk of Atherosclerotic Cardiovascular (ASCVD) Events in Adults across Kaiser Permanente Northern California
Jamal Rana | Community Health | 2025
Evaluating the relationship between coronary artery calcium score and cardiovascular events by race/ ethnicity in a large, diverse integrated healthcare system
Seema Pursnani | Community Health | 2025
Long-Term Echocardiographic and Clinical Outcomes of Patients Receiving Transcatheter Aortic Valve Replacement within Kaiser Permanente Northern California
Emily Perdoncin | Community Health | 2025
Comparative Assessment of Coronary Revascularization Strategies on Dementia Incidence in Older Adults with an Acute Coronary Syndrome
Ashok Krishnaswami | Community Health | 2025
The Kaiser Permanente Cardiovascular Health Enhancement and Monitoring for Oncology (KP CHEMO) study
Samir Thadani, Andrew Ambrosy | Delivery Science Grants Program | 2025
Polygenic Risk Score and Early-onset Coronary Heart Disease in the GERA Cohort
Jamal Rana, Carlos Iribarren | Targeted Analysis Program | 2024
Characterizing the development of cardiovascular disease in women after adverse pregnancy outcomes.
Victoria Woo | Community Health | 2024
Epidemiology and Outcomes for Patients with Bicuspid Aortic Valve
Matthew Solomon | Community Health | 2024
Improving Risk Stratification for Patients with Thoracic Aortic Aneurysm
Dorinna Mendoza | Community Health | 2024
Heart Failure Epidemiology and Risk Prediction of Outcomes In Adults with Chronic Kidney Disease (HEROIC)
Andrew Ambrosy | Community Health | 2024
Improving quality by TARGETing LDL using a systems-based approach to evaluate our current performance (TARGET-LDL)
Adam Rogers, Carlos Iribarren | Delivery Science Grants Program | 2023 | View Summary
Improved Outcomes with Home-Based Cardiac Rehabilitation-Experience from a Large Integrated Heathcare System
Uma Vadlakonda, Mary Reed, Brandon Horton | Rapid Analytics Unit | 2023 | View Summary
Characterizing the development of cardiovascular disease in women after adverse pregnancy outcomes.
Victoria Woo | Community Health | 2023
Pregnancy outcomes in women with cardiovascular disease: a retrospective cohort study from Kaiser Permanente Northern California
Seema Pursnani | Community Health | 2023
[2022 Continued Funding] Objective cardiac testing following emergency department evaluations for chest pain: associations between referral for non-invasive cardiac testing and 2-year adverse outcomes.
Dustin Mark | Community Health | 2023
Validation of a Novel Algorithm for Emergency Department Patients with Possible Acute Coronary Syndromes Following the Transition to a High-Sensitivity Troponin Assay
Dustin Mark, Mary Reed | Delivery Science Grants Program | 2023 | View Summary
Improving Care by Defining the Role of ElectroNic HealTh Record-Based Alerts In a Fully Integrated Health Care Delivery SYstem for Worsening Heart Failure (IDENTIFY-WHF)
Drew Ambrosy | Delivery Science Grants Program | 2023
Accuracy of Prenatal Detection of Clinically Significant Congenital Heart Disease Among Still- and Live-Births at Kaiser Permanente Northern California
Kavin Desai, Julie Schmittdiel, Rika Alavi | Rapid Analytics Unit | 2021 | View Summary
Optimizing Management of Valvular Heart Disease
Matthew Solomon, MD, PhD | Physician Researcher Program | 2021
No Differences in ED Visits, Hospitalizations, or Mortality Among Heart Failure Patients with Remote Telemonitoring
Amir Axelrod, Andrew Ambrosy, Alan Go | Delivery Science Grants Program | 2020 | View Summary
Predicting Adverse Outcomes and Poorer Quality of Life After TAVR is Challenging in Real World Populations
Ed McNulty, Alan Go | Delivery Science Grants Program | 2019 | View Summary
Identification and management of familial hypercholesterolemia in an integrated health care delivery system.
Richard Birnbaum | Rapid Analytics Unit | 2019 | View Summary
Implementation of Familial Hypercholesterolemia and template transition protocol
Richard Birnbaum, Andy Avins, Brandon Horton | Rapid Analytics Unit | 2019
Management and outcomes of patients with valvular heart disease
Matt Solomon, Alan Go | Physician Researcher Program | 2017 | View Summary
Heart failure readmission intervention
Keane Lee, Alan Go | Delivery Science Grants Program | 2016
Use and outcomes of CT angiography
Jamal Rana, Alan Go | Delivery Science Grants Program | 2016 | View Summary
Natural History of Thoracic Aortic Aneurysm and Acute Aortic Dissection
Matt Solomon | Community Health | 2013
Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Chronic Total Occlusion
Amit Sachdeva | Community Health | 2013
Healthy Eating as a Means for Active Living in Heart Failure (HEAL-HF)) Study
Andrew Ambrosy, Alan Gl, Nancy Gordan | Community Health | 2013
Impact of wildfire air pollution on rates of cardiovascular events and mortality
Stacey Alexeeff | Community Health | 2013
Rate versus Rhythm Control in Young Patients with Atrial Fibrillation: The KP YOUNG-AF Study
Matthew Solomon | Community Health | 2013
The Use of Natural Language Processing to Characterize Episodes of Outpatient Worsening Heart Failure within an Integrated Health Care Delivery System
Ambrosy, Andrew, MD | Community Health | 2013
Contemporary Risk Stratification in Adults with Heart Failure and Reduced Ejection Fraction
Adatya, Sirtaz, MD | Community Health | 2013
Effect of lipid (LDL) monitoring on patients’ statin adherence and physician practice behaviors after an ASCVD event.
Rana, Jamal MD PhD | Community Health | 2013
Clinical Characteristics, Periprocedural Complications, and Outcomes of Patients with Severe Aortic Stenosis Undergoing Elective versus Urgent/Emergent Transcatheter Aortic Valve Replacement within an Integrated Health Care Delivery System
Mishell, Jacob MD | Community Health | 2013
Comparison of high risk elective percutaneous coronary intervention in CV surgery back-up sites versus non-CV surgical back-up sites
Shah, Ahmed MD | Community Health | 2013
Epidemiology and Outcomes for Thoracic Aortic Aneurysms and Acute Aortic Dissections
Matt Solomon | Community Health | 2013
Duration of thienopyridine therapy and outcomes after PCI for chronic total occlusions
Amit Sachdeva | Community Health | 2013
Ticagrelor vs. Clopidogrel in Acute Coronary Syndromes: A Real-World, Community-Based Comparison of Ischemic and Bleeding Outcomes
Amit Sachdeva | Community Health | 2013
Severe Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease (ASCVD) in Patients with Diabetes
Jamal Rana | Community Health | 2013
Status and impact of Ideal Cardiovascular Health, as defined by American Heart Association, among KPNC population
Jamal Rana | Community Health | 2013
Assessing Glycosylated Hemoglobin (HbA1c) Thresholds for Development of Cardiovascular Disease by Racial-Ethnic Groups
Seema Pursani | Community Health | 2013
Clopidogrel Duration after Chronic Total Occlusion Percutaneous Coronary Intervention
Amit Sachdeva | Community Health | 2013
Interaction Between Choice of Anticoagulation, Antiplatelet Therapy and Access Site on Mortality and Bleeding after Percutaneous Coronary Intervention: Insights from the California National Cardiovascular Data Registry ( NCDR) and KP PCI Registry
Femi Philip | Community Health | 2013
CABG vs PCI in Older Acute Coronary Syndrome (ACS) patients: Impact of revascularization strategy on outcomes
Ahmed Shah | Community Health | 2013
Development of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Choon Goh | Community Health | 2013
Predictors of Post-PCI Resource Utilization and Outcomes
Matt Solomon | Industry | 2013
Disparities in Redidual Risk in Patients Reveiving Statins for Primary or Secondary Prevention at an Integrated Health Care Delviery System (KP Reach)
Andrew Ambrosy | Industry | 2013
Evaluating Inpatient and Outpatient Encounters Within a Learning and Integrated Health Care Delivery Organization Due to Worsening Heart Failure
Andrew Ambrosy, Alan Go | Industry | 2013
Transcatheter Mitral-Valve Repair in Patients with Heart Failure and Functional Mitral Regurgitation – Potential Scope and Clinical Benefit of Early Adoption at an Integrated Healthcare Delivery System
Andrew Ambrosy | Industry | 2013
KP Real-world Heart Monitoring StrategY Evaluation, Treatment Patterns and Health Metrics (RHYTHM) Study
Matt Solomon, Alan Go | Industry | 2013
Adherence to Guideline Recommendations for Secondary Prevention and Mortality after Acute MI
Matt Solomon, Alan Go | Industry | 2013
KP Post-PCI Outcomes and Resource Utilization Study, and Development and Validation of a KP Post-PCI Risk Calculator
Matt Solomon | Industry | 2013
Hypercoagulability in mechanical circulatory support
Sirtaz Adatya | Industry | 2013
GUARD AF: Screening for atrial fibrillation in high risk patients
Alan Go, Drew Ambrosy, Matt Solomon | Industry | 2013
PIONEER-HF: A large, multi-center randomized clinical trial of sacubitril- valsartan versus enalapril in heart failure
Drew Ambrosy | Industry | 2013
MITRALIGN CLPR- 010 SCOUT: Early Feasibility Of The Mitralign Percutaneous Tricuspid Valve Annuloplasty System (Ptvas) For Symptomatic Chronic Functional Tricuspid Regurgitation CLPR-010
Andrew Rassi | Industry | 2013
MEDTRONIC APOLLO: Transcatheter Mitral Valve Replacement with the Medtronic Intrepid™ TMVR System in patients with severe symptomatic mitral regurgitation
Jacob Mishell | Industry | 2013
EVALVE 11-512- COAPT: A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects
Jacob Mishell | Industry | 2013
EDWARDS 2018-07 CLASP III: A trial to evaluate safety and effectiveness of transcatheter mitral valve repair with the Edwards PASCAL Transcatheter Mitral Valve Repair System compared to Abbott MitraClip in patients with degenerative mitral regurgitation
Andrew Rassi | Industry | 2013
EDWARDS 2017-05 ACTIVE: A trial to assess transcatheter mitral valve repair with Edwards Cardioband System and guideline directed medical therapy (GDMT) compared to GDMT alone in patients with functional mitral regurgitation (FMR) and heart failure
Andrew Rassi | Industry | 2013
EDWARDS EARLY TAVR: Evaluation of Transcatheter Aortic Valve Replacement Compared to Surveillance for Patients with AsYmptomatic Severe Aortic Stenosis: EARLY TAVR trial 2016-07 EARLY TAVR SAPIEN 3 Transcatheter Heart Valve G160259
Richard Richter | Industry | 2013
EDWARDS 2015-08 AVIV: A Prospective, Single-Arm, Multicenter Study to Investigate the Safety and Effectiveness of SAPIEN 3 Transcatheter Heart Valve Implantation in Patients With a Failing Aortic Bioprosthetic Valve
Edward McNulty | Industry | 2013
CORVIA 1601 REDUCE LAP HF: A study to evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure
Ann Sheridan | Industry | 2013
EDWARDS 2015-08 P3: A study to establish the safety and Effectiveness of the Sapien 3 Transcatheter Heart Valve in low risk patients who have severe, calcific, aortic stenosis requiring Aortic Valve Replacement
Edward McNulty | Industry | 2013
BSC S2073 EVOLVE: Study assessing safety of 3-month dual antiplatelet therapy (DAPT) in subjects at high risk for bleeding undergoing percutaneous coronary intervention (PCI) with the SYNERGYTM Everolimus-Eluting Platinum Chromium Coronary Stent System
Andrew Rassi | Industry | 2013
Assessing Syndemics of Cardiovascular Disease in People with and without HIV
Michael Silverberg | NIH | 2013
Long-Term Outcome in Unruptured Brain Arteriovenous Malformation Patients
Helen Kim | NIH | 2013
Coronary Artery Risk Development in Young Adults (CARDIA) Study
Jamal Rana | NIH | 2013
Multicenter Arteriovenous malformation Research Study (MARS) extension
Jon Zaroff, Helen Kim | NIH | 2013
Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation
Jon Zaroff, Kiran Khush | NIH | 2013
Association of multimorbidity in older adults after permanent pacemaker placement
Ashok Krishnaswami | Unfunded | 2013
Acute Emergency Care and Outcomes for Stroke, Myocardial Infarction, and Surgery During the COVID-19 Pandemic in Kaiser Permanente Northern California: Implications for Care Delivery During COVID-19 Recovery Phase and Future Surges
Mai Nguyen-Huynh, Matthew Solomon, David Vinson, Robert Chang | Other | 2013
Effectiveness of Care Processes Recommended to Improve Perioperative Cardiovascular Risk Management for Noncardiac Surgery
Lisa Herrinton | Other | 2013
Clinical Characteristics of COVID-19 in Solid Organ Transplant Recipients
Dana Weisshaar | Other | 2013
Long-term follow up of maternal outcomes in peripartum cardiomyopathy
Seema Pursnani | Other | 2013
Atherosclerotic cardiovascular disease risk in South Asians by statin use
Seema Pursnani | Other | 2013
Understanding the impact of race/ethnicity and gender on cardiovascular outcomes following CABG
Seema Pursnani | Other | 2013
Assessing the impact of the COVID-19 pandemic on glycemic control and covid-19 infection in diabetic patients
Seema Pursnani | Other | 2013
A Pragmatic Randomized Controlled Trial of a Bundled, Pharmicist-Led Hyper-polypharmacy Deprescribing Intervention
Lynn Deguzman, Maisha Draves, Lisa Herrinton | Other | 2013
Outcomes of the Heart Health for South Asians (HHSA) Program
Seema Pursnani | Other | 2013
Periprocedural Code Status for TAVR
Gwen Bernacki | Other | 2013
Comprehensive assessment of harm and benefit in SPRINT
Ashok Krishnaswami | Other | 2013
HIV Risk of Developing Heart Failure by Age, Gender and Race/Ethnicity: The HIV HEART Study
Alan Go, Michael Siverberg | Other | 2013
HIV Infection and Risks of Morbidity and Death in Adults with Incident Heart Failure
Alan Go, Michael Siverberg | Other | 2013
The PERFUSE SCAD Registry
Sahar Naderi | Other | 2013
Systematic Review of the role of age in cardiac imaging
Ashok Krishnaswami | Other | 2013
Addressing Age and Blood Pressure – Utilizing a National Database
Ashok Krishnaswami | Other | 2013
Use of Elixhauser Comorbidity Index in risk stratifying participants referred for Permanent Pacemaker placement
Ashok Krishnaswami | Other | 2013
Pulse Pressure, Treatment Intensity in Participants of the SPRINT trial
Ashok Krishnaswami | Other | 2013
Deprescribing CV and non-CV medications
Ashok Krishnaswami | Other | 2013
Changes in weight, lipids, blood pressure, health care utilization and CV outcomes in participants of the Medical Weight Management Program
Ashok Krishnaswami | Other | 2013
Examination of the Acute Effects of Azithromycin Use on Cardiovascular Mortality, as Compared with Amoxicillin and Levofloxacin
Jon Zaroff | Industry | 2013
Familial hypercholesterolemia II – manuscript
Richard Birnbaum, Andy Avins, Brandon Horton | Rapid Analytics Unit | 2013
